The Safety and Efficacy of Microbial Ecosystem Therapeutic-2 in People With Major Depression: A Phase 2, Double-Blind, Placebo-Controlled Study

微生物生态系统 Therapeutic-2 对重度抑郁症患者的安全性和有效性：第 2 阶段、双盲、安慰剂对照研究

• 批准号: 458788
• 负责人: Chinna Meyyappan Arthi
• 金额: $ 7.65万
• 依托单位: Queen's University (Kingston, Ontario)
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-11-01 至 2024-11-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=458788&lang=en
• 关键词: Anxiety; Clinical Interviewing; Depression; Gut-Brain Axis; Microbe Therapy; Phase 2 Clinical Trial; Probiotics

The gut-brain axis (GBA) is a bidirectional signalling pathway between our brain and our gastrointestinal tract. The GBA is currently being studied because of its potential relationship with our mood, anxiety, and related symptoms. Past research on the re

肠脑轴（GBA）是我们大脑和胃肠道之间的双向信号通路。GBA目前正在研究，因为它与我们的情绪，焦虑和相关症状的潜在关系。过去的研究